An Overview of Medications for HIV and AIDS
There are a number of drugs that have been approved for the treatment of
HIV (human immunodeficiency virus) and
AIDS. These medications fall into a number of different groups, or "classes," of HIV drugs. Most people with HIV or AIDS take medications from several of these classes.
Current research is focused on finding new HIV medicines, particularly medicines that can work in new ways. Because the HIV virus can mutate rapidly, it often becomes resistant to available HIV medications -- which is why finding new types of HIV medications is so important.
The Different Classes of HIV Drug Treatments
The available classes of HIV medications include the following:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
- Nucleotide reverse transcriptase inhibitors (NtRTIs)
- Protease inhibitors
- Entry inhibitors, including fusion inhibitors
- Integrase inhibitors
- Combination medications from different classes.
Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
The very first HIV drug discovered,
zidovudine (
Retrovir®), is an NRTI. Other NRTIs include:
These medicines work by blocking a process that the HIV virus needs in order to multiply.
HIV (human immunodeficiency virus) is the virus that causes AIDS. Like other viruses, HIV must use a person's own cells to reproduce. However, HIV is a little different than other viruses because it must first convert its genetic material from RNA to DNA. It is the DNA genes that allow HIV to multiply.
HIV alters its genetic material by using a special protein called the reverse transcriptase enzyme. To create DNA, this enzyme uses several different protein building blocks.
An NRTI medication works by tricking reverse transcriptase into thinking it is one of these protein building blocks. However, it is just different enough that when used to create DNA, NRTIs actually stop the DNA from being made. Without DNA, HIV cannot multiply.